2016
DOI: 10.1111/eci.12585
|View full text |Cite
|
Sign up to set email alerts
|

Renal microRNA‐ and RNA‐profiles in progressive chronic kidney disease

Abstract: These results suggest the involvement of specific miRNAs and mRNAs in biological pathways associated with the progression of CKD.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
70
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 99 publications
(73 citation statements)
references
References 54 publications
(67 reference statements)
2
70
0
1
Order By: Relevance
“…CCL19 has been reported to be expressed by cultured podocytes and kidneys suffering from chronic glomerular diseases (65,66). Given the acuity of our model, it is unlikely the effect we noted on renal function following DT therapy resulted from depletion of CCL19-expressing cells of normal kidneys.…”
Section: Discussionmentioning
confidence: 87%
“…CCL19 has been reported to be expressed by cultured podocytes and kidneys suffering from chronic glomerular diseases (65,66). Given the acuity of our model, it is unlikely the effect we noted on renal function following DT therapy resulted from depletion of CCL19-expressing cells of normal kidneys.…”
Section: Discussionmentioning
confidence: 87%
“…miR-22 was found down-regulated in clear cell renal cell carcinoma (RCR) samples when compared to adjacent non-tumorous samples (He et al , 2015). The expression of miR-128 was reported also as down-regulated in the kidneys of patients with progressive versus stable chronic kidney disease (Rudnicki et al , 2016). In vitro studies in human embryonic kidney cells (HEK293T) suggest an anti-proliferative role for miR-128 through apoptosis regulation (Adlakha and Saini, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…miR-30a-3p was decreased in acute cellular rejection50. miR-30d-5p was down-regulated in progressive kidney disease from diabetic and/or hypertensive nephropathy51. TGF-ß treatment of podocytes in vitro resulted in a diminished expression of all miR-30 family members52.…”
Section: Discussionmentioning
confidence: 99%